These observations are further supported by a systematic review and meta-analysis of five retrospective studies encompassing more than 156,000 individuals with T2DM, which found a nonsignificant trend toward reduced glaucoma incidence (HR 0.78, 95% CI 0.59–1.04).
← all excerpts
Glucagon-like Peptide-1 Receptor Agonists and Ocular Disease: Mechanisms, Evidence and Therapeutic Perspectives.
1
—
—